Search Results - "Khanani, Saleem A."
-
1
Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in lung cancer patients receiving carboplatin-based therapies
Published in Journal of clinical oncology (20-05-2017)“…Abstract only e21685 Background: Chemotherapy-induced nausea and vomiting (CINV) is a distressing symptom of cancer treatment; in lung cancer, carboplatin is…”
Get full text
Journal Article -
2
A phase III, randomized, double-blind study of single-dose intravenous fosaprepitant in preventing chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
3
Phase III design for a trial of single-dose fosaprepitant (FA) in preventing chemotherapy-induced nausea and vomiting (CINV) associated with moderately emetogenic chemotherapy (MEC)
Published in Journal of clinical oncology (20-05-2014)“…Abstract only…”
Get full text
Journal Article